v3.26.1
Note 2 - Revenue (Tables)
3 Months Ended
Jun. 30, 2026
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

Three Months Ended June 30, 2026

 
  

Sterilization and Disinfection Control

  

Biopharmaceutical Development

  

Calibration Solutions

  

Clinical Genomics

  

Total

 
                     

Consumables

 $21,925  $4,303  $810  $7,739  $34,777 

Hardware and software

  96   4,898   7,681   1,450   14,125 

Services

  2,484   2,858   4,794   1,100   11,236 

Total revenue

 $24,505  $12,059  $13,285  $10,289  $60,138 
  

Three Months Ended June 30, 2025

 
  

Sterilization and Disinfection Control

  

Biopharmaceutical Development

  

Calibration Solutions

  

Clinical Genomics

  

Total

 
                     

Consumables

 $23,011  $3,836  $841  $8,085  $35,773 

Hardware and software

  89   4,288   6,975   1,217   12,569 

Services

  2,310   3,362   4,534   995   11,201 

Total revenue

 $25,410  $11,486  $12,350  $10,297  $59,543 
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table Text Block]
  

Three Months Ended June 30,

 
  

2026

  

2025

 

United States

 $29,743  $27,646 

China

  5,437   5,429 

Other

  24,958   26,468 

Total revenue

 $60,138  $59,543 
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities as of March 31, 2026

 $14,723 

Prior year liabilities recognized in revenue during the three months ended June 30, 2026

  (3,917)

Contract liabilities added during the three months ended June 30, 2026, net of revenue recognized

  3,717 

Contract liabilities as of June 30, 2026

 $14,523